News Focus
News Focus
Followers 258
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: iclight post# 164062

Wednesday, 11/16/2016 5:20:29 PM

Wednesday, November 16, 2016 5:20:29 PM

Post# of 405181
Here is how the lesion disappearance was reported:
" According to information supplied by the hospital, the patient, who successfully completed three Kevetrin 3-dose cycles before discontinuing the trial, experienced increased energy, while scans showed a reduction in the amount of peritoneal fluid (ascites) during treatment with Kevetrin. Subsequent to the second and third Kevetrin cycles, scans showed the spleen lesion to be essentially undetectable and the patient’s disease to be clinically stable." - See more at: http://cellceutix.com/cellceutix-reports-spleen-lesion-disappears-in-patient-with-metastatic-stage-4-ovarian-cancer-in-clinical-trial-of-anti-cancer-drug-kevetrin/#sthash.rI8bYvEQ.dpuf

So Dana Farber reported this, though I guess we have to take Leo's word that Dana Farber did report it. Never mind that if the account is factually incorrect, all hell would have broken loose from the Dana Farber side.

Bunny goes to Hawaii

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y